LifeSci Capital
Tracked across 5 events · 41 articles · First seen Feb 19, 2026 · Last active Apr 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
LifeSci Capital is acting as the lead manager for Candel Therapeutics' public offering, playing a significant role in guiding the offering process.
Feb 19, 2026 · 9 articles
Business
LifeSci Capital served as a joint book-running manager for Eupraxia Pharmaceuticals' public offering.
Feb 19, 2026 · 7 articles
Business
LifeSci Capital is acting as a bookrunner for Larimar Therapeutics' public offering.
Feb 25, 2026 · 7 articles
Business
LifeSci Capital is serving as Compass Pathways' financial advisor for the public offering, offering guidance on the transaction.
Feb 19, 2026 · 7 articles
Business
LifeSci Capital acted as a co-lead manager for the public offering, supporting the bookrunning managers in the transaction.
Apr 01, 2026 · 11 articles
Compass Pathways
financial advisor
↔
LifeSci Capital
LifeSci Capital is the financial advisor to Compass Pathways for the offering.
Candel Therapeutics
lead manager
↔
LifeSci Capital
LifeSci Capital is the lead manager for Candel Therapeutics' public offering.
NEWSDESK
Track LifeSci Capital live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard